<DOC>
	<DOCNO>NCT03082976</DOCNO>
	<brief_summary>A prospective , multi-centre , epidemiological observational study design evaluate prevalence BRCA1 BRCA2 ( BReast CAncer gene ) mutation current newly diagnose ovarian cancer patient across different country Gulf region . This study also describe epidemiological feature disease enrolled patient .</brief_summary>
	<brief_title>Prevalence BRCA1 BRCA2 Mutations Ovarian Cancer Patients Gulf Region</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>1 . Subjects willing sign inform consent form ( ICF ) 2 . Female subject 18 year age old 3 . Have histologically confirm diagnosis Federation Gynecology Obstetrics ( FIGO ) ovarian epithelial , primary peritoneal cancer make one following : 1 . Standard stag laparotomy include bilateral salpingooophorectomy , omentectomy , lymph node sample debulking and/or 2 . Surgical resection radiographic evidence consistent ovarian cancer 3 . Paracentesis biopsy radiographic evidence consistent ovarian cancer ( normal appear pancreas , liver , gastrointestinal tract ) . 4 . Have availability paraffinembedded archived tumor tissue block ( prefer ) , block possible , minimum twenty 10um section . Patients meet follow criterion ineligible participate study hence consent : 1 . The diagnosis primary ovarian cancer ; thus , patient exclude previous cancer metastasize ovary , secondary malignancy associate ovarian cancer . 2 . Is able willing provide write informed consent . 3 . Have diagnosis severe acute chronic medical psychiatric condition may increase risk associate study participation may interfere interpretation study . 4 . Be patient , judgment Investigator , would inappropriate enrollment study . A rationale document patient screen ultimately exclude study result meeting aforementioned exclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>